VYNE Therapeutics Inc. - Common Stock — 재무제표 (NASDAQ:VYNE) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 93.74 M67.05 M40.76 M97.69 M66.91 M30.16 M 총 부채 56.25 M18.41 M9.35 M8.95 M14.82 M2.4 M 자본금 총액 37.49 M48.64 M31.2 M88.73 M52.09 M27.77 M 총 부채 및 주주자본 93.74 M67.05 M40.76 M97.69 M66.91 M30.16 M 총부채 33.17 M0———— 순부채 -26.23 M-42.9 M————

뉴스

VYNE 테라퓨틱스, 야로우 바이오사이언스와 2억 달러 규모 합병

VYNE Therapeutics to merge with Yarrow Bioscience in $200 million deal

VYNE Therapeutics Inc. (VYNE) Yarrow Bioscience, Inc. - M&A Call Prepared Remarks Transcript

바이오 합병 소식에 바이오젠 주가 급등

Vyne Therapeutics stock soars after merger with Yarrow Bioscience

VYNE and Yarrow Bioscience to merge in all-stock transaction

Crude Oil Rises Over 1%; General Mills Earnings Top Views - DBV Technologies (NASDAQ:DBVT), General Mills (NYSE:GIS)

Dow Jumps 150 Points; Jabil Posts Upbeat Earnings - Aditxt (NASDAQ:ADTX), Agape ATP (NASDAQ:ATPC)

VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue Estimates

VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates

Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates

Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates